HCA Healthcare, Inc. Reports First Quarter 2026 Results with Steady Revenue Growth and Strong Cash Flow
HCA Healthcare one of the largest healthcare service providers in the United States, has announced its financial and operating results for the first quarter ended March 31, 2026. The company delivered steady revenue growth and solid operational performance despite facing a dynamic and somewhat challenging healthcare environment.
Strong Financial Performance in Q1 2026
For the first quarter of 2026, HCA Healthcare reported total revenues of $19.109 billion, representing a 4.3% increase compared to $18.321 billion in the same period of 2025. This growth reflects the company’s continued ability to expand its services and maintain strong patient demand across its network of hospitals and healthcare facilities.
Net income attributable to the company reached $1.620 billion, a modest 0.6% increase from $1.610 billion reported in the first quarter of 2025. While net income growth was relatively flat, profitability metrics improved significantly when viewed on a per-share basis.
Diluted earnings per share (EPS) rose to $7.15, up from $6.45 in the prior-year period, marking a 10.9% increase. This improvement highlights the company’s focus on operational efficiency, disciplined cost management, and share repurchase activity.
Adjusted EBITDA, a key non-GAAP measure used to evaluate operational performance, totaled $3.802 billion, reflecting a 1.9% increase compared to $3.733 billion in the same quarter last year.
Operational Trends and Patient Volumes
Operationally, HCA Healthcare experienced modest growth in patient volumes during the first quarter. Same facility admissions increased 0.9%, while same facility equivalent admissions rose 1.3% year-over-year. These figures indicate stable demand across the company’s healthcare network.
Emergency room visits also showed slight growth, increasing 0.3% compared to the first quarter of 2025. However, certain service lines experienced declines. Same facility inpatient surgeries decreased 0.3%, and outpatient surgeries fell 1.7%, reflecting shifts in patient behavior and procedural trends.
Despite these mixed volume trends, revenue per equivalent admission increased 3.1%, demonstrating improved pricing, payer mix, and reimbursement rates.
Impact of External Factors on Volumes
The first quarter of 2026 did not follow typical seasonal patterns for healthcare utilization. According to company leadership, reduced respiratory illness activity significantly impacted patient volumes.
Respiratory-related admissions declined sharply by 42%, while respiratory-related emergency room visits dropped 32% compared to the prior-year period. These declines suggest a milder respiratory season relative to 2025, which had previously driven higher patient volumes.
Additionally, a winter storm in January disrupted operations in several markets, further affecting patient visits and admissions during the quarter.
Despite these headwinds, HCA Healthcare managed to offset much of the volume-related impact through favorable reimbursement developments. The recognition of certain Medicaid supplemental programs—previously not included in the company’s initial 2026 guidance—helped stabilize financial performance.
Leadership Perspective
Commenting on the results, Sam Hazen, Chief Executive Officer of HCA Healthcare, acknowledged the evolving environment in which the company operates.
He emphasized the resilience and adaptability of the organization’s workforce, noting that employees continue to deliver high-quality care while navigating changing conditions. His remarks highlighted the importance of operational agility in maintaining performance amid external uncertainties.
Balance Sheet and Liquidity Position
HCA Healthcare ended the first quarter with a solid balance sheet and strong liquidity. As of March 31, 2026, the company reported:
- Cash and cash equivalents: $940 million
- Total assets: $61.450 billion
- Total debt: $48.023 billion
During the quarter, capital expenditures totaled $1.119 billion, excluding acquisitions. These investments reflect the company’s ongoing commitment to expanding capacity, upgrading facilities, and enhancing healthcare delivery infrastructure.
Cash flow from operating activities was particularly strong, totaling $2.014 billion, a 22.0% increase from $1.651 billion in the first quarter of 2025. This improvement underscores the company’s ability to generate robust cash flows, even in a softer volume environment.
Share Repurchases and Capital Allocation
HCA Healthcare continued to return capital to shareholders through its share repurchase program. During the first quarter of 2026, the company repurchased 3.157 million shares of its common stock at a total cost of $1.571 billion.
As of March 31, 2026, approximately $9.179 billion remained available under the company’s share repurchase authorization, providing significant flexibility for future capital returns.
Additionally, the company maintained strong access to liquidity, with $4.336 billion available under its credit facility after accounting for letters of credit and reserves supporting its commercial paper program.
Dividend Announcement
HCA Healthcare also reaffirmed its commitment to shareholder returns by announcing a quarterly cash dividend. The company’s Board of Directors declared a dividend of $0.78 per share, which will be paid on June 30, 2026, to shareholders of record as of June 16, 2026.
The company noted that future dividend payments will remain subject to board discretion and will depend on various factors, including financial performance, cash flow generation, and broader economic conditions.
2026 Financial Guidance
Looking ahead, HCA Healthcare reaffirmed its previously issued financial guidance for the full year 2026, which was initially provided on January 27, 2026.
The company’s outlook is based on several key assumptions, including:
- Continued, though moderate, volume growth
- A relatively stable operating environment
- Consistent payer mix and reimbursement trends
- Ongoing healthcare policy developments
- Inflationary pressures and broader economic conditions
- Potential impacts of trade policies, including tariffs
The guidance also reflects expectations regarding the healthcare insurance exchange landscape, particularly in light of administrative reforms and the expiration of enhanced premium tax credits.
Importantly, the company’s projections exclude certain potential future events, such as gains or losses from facility sales, debt retirement costs, legal claims, and asset impairments. It also does not account for possible future approvals related to Medicaid directed and supplemental payment programs.
Strategic Positioning and Outlook
Despite the mixed operational environment in the first quarter, HCA Healthcare remains well-positioned for the remainder of 2026. The company’s scale, diversified service offerings, and strong financial foundation provide resilience against fluctuations in patient volumes and external disruptions.
The combination of disciplined cost management, strategic investments, and favorable reimbursement developments is expected to support continued performance throughout the year.
Moreover, the company’s ability to generate strong cash flows and return capital to shareholders underscores its financial strength and operational efficiency.
Investor Conference Call
To discuss these results in more detail, HCA Healthcare scheduled a conference call for investors at 9:00 a.m. Central Time on the day of the announcement. The call includes management’s commentary on performance, strategic priorities, and outlook, along with a question-and-answer session.
Investors and interested parties can access the live audio broadcast through the company’s investor relations website.
In summary, HCA Healthcare delivered a solid start to 2026, marked by steady revenue growth, improved earnings per share, and strong cash flow generation. While the company faced headwinds from lower respiratory-related volumes and weather disruptions, these challenges were largely offset by favorable reimbursement factors and operational discipline.
With reaffirmed guidance, ongoing capital investments, and a continued focus on delivering high-quality care, HCA Healthcare remains on track to navigate the evolving healthcare landscape and sustain long-term growth.
About the Company
As of March 31, 2026, HCA operated 189 hospitals and approximately 2,600 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 19 states and the United Kingdom.
